Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Invasive fungal infections".)
International
●International Society for Heart and Lung Transplantation (ISHLT): Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients – Executive summary, 2015 (published 2016)
●World Health Organization (WHO): Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults (2014)
●A research agenda on the management of intra-abdominal candidiasis – Results from a consensus of multinational experts (2013)
●Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society for Blood and Marrow Transplant (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Association of Medical Microbiology and Infectious Diseases (AMMI), Center for Disease Control and Prevention (CDC), and Health Resources and Services Administration (HRSA): Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients – A global perspective (RETIRED; published 2009)
Canada
●Public Health Agency of Canada (PHAC): Canadian Guidelines on Sexually Transmitted Infections – STI-associated syndromes guide: Vaginitis (2023)
●Canadian Paediatric Society (CPS): Practice point on antifungal agents for common outpatient paediatric infections (2019)
●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on vulvovaginitis – Screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis (2015)
United States
●National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Candidiasis (mucocutaneous)
●NIH, CDC, the HIVMA of the IDSA, and Pediatric Infectious Diseases Society (PIDS): Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV – Candida infections
●American Academy of Pediatrics (AAP): Red Book – Candidiasis (2021)
●CDC: Sexually transmitted infections treatment guidelines – Vulvovaginal candidiasis (VVC) (2021)
●American Society of Transplantation (AST): Guidelines on Candida infections in solid organ transplantation (2019)
●American Thoracic Society (ATS): An official clinical practice guideline on microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice (2019)
●American Society of Clinical Oncology (ASCO) and IDSA: Clinical practice guideline on antimicrobial prophylaxis for adult patients with cancer-related immunosuppression, update (2018)
●IDSA: Clinical practice guideline for the management of candidiasis, update (2016)
●ATS: An official statement for the treatment of fungal infections in adult pulmonary and critical care patients (2011)
Europe
●European Society of Intensive Care Medicine (ESICM)/European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Task force on practical management of invasive candidiasis in critically ill (2019)
●European Conference on Infections in Leukaemia (ECIL): European guidelines for primary antifungal prophylaxis in adult haematology patients – Summary of the updated recommendations (2018)
●ECIL: Guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (2017)
●ECIL: Guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation (2014)
●ECIL: Recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients (2012)
●ESCMID: Guideline for the diagnosis and management of Candida diseases – Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT) (2012)
●ESCMID: Guideline for the diagnosis and management of Candida diseases – Diagnostic procedures (2012)
●ESCMID: Guideline for the diagnosis and management of Candida diseases – Non-neutropenic adult patients (2012)
●ESCMID: Guideline for the diagnosis and management of Candida diseases – Patients with HIV infection or AIDS (2012)
●ESCMID: Guideline for the diagnosis and management of Candida diseases – Prevention and management of invasive infections in neonates and children caused by Candida spp (2012)
United Kingdom
●British Association of Sexual Health and HIV (BASHH): National guideline for the management of vulvovaginal candidiasis (2019)
●Public Health England (PHE): Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris (2016, updated 2017)
●British Society for Medical Mycology (BSMM): Best practice recommendations for the diagnosis of serious fungal diseases (2015)
Australia–New Zealand
●Australasian Sexual Health Alliance (ASHA): STI management guidelines for use in primary care – Candidiasis (2021)
●Royal Australasian College of Physicians (RACP): Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation (2021)
●RACP: Consensus guidelines for antifungal stewardship, surveillance and infection prevention (2021)
●RACP: Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes inpatients with haematological malignancy and haemopoietic stem cell transplant recipients (2021)
●RACP: Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings (2021)
Japan
●[In Japanese] Japanese Society of Mycology (JSMM): Clinical practice guidelines for management of invasive candidiasis (2021)
●[In English] Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis (2015)
